|
|
| | Insulin-like Growth Factor-1 Receptor Inhibitor Basic information |
| Product Name: | Insulin-like Growth Factor-1 Receptor Inhibitor | | Synonyms: | 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone;BMS-536924;Insulin-like Growth Factor-1 Receptor Inhibitor;4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-morpholinyl)-1H-benzimidazol-2-yl]- 2(1H)-pyridinone;CS-0117;HY-10262;BMS-536924
Insulin-like Growth Factor-1 Receptor Inhibitor;BMS-536924, >=98% | | CAS: | 468740-43-4 | | MF: | C25H26ClN5O3 | | MW: | 479.96 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 468740-43-4.mol |  |
| | Insulin-like Growth Factor-1 Receptor Inhibitor Chemical Properties |
| Melting point | >206°C (dec.) | | density | 1.44 | | storage temp. | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C | | solubility | DMSO (Slightly) | | pka | 10.40±0.10(Predicted) | | form | Solid | | color | Light Yellow to Yellow | | CAS DataBase Reference | 468740-43-4 |
| | Insulin-like Growth Factor-1 Receptor Inhibitor Usage And Synthesis |
| Uses | BMS 536924 is an inhibitor of insulin-like growth factor receptor (IGF1R) kinase and insulin receptor. BMS 536924 was reported to have antitumor activity. | | Definition | ChEBI: 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-morpholinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-pyridinone is a member of benzimidazoles. | | storage | Store at -20°C |
| | Insulin-like Growth Factor-1 Receptor Inhibitor Preparation Products And Raw materials |
|